CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Russell Alan J Chief Scientific Officer | Option exercise 10b5-1 | +130,352 | $0.45 | $59K | 154,907 |
| 2026-07-01 | Russell Alan J Chief Scientific Officer | Option exercise 10b5-1 | +69,648 | $0.18 | $13K | 224,555 |
| 2026-07-01 | Russell Alan J Chief Scientific Officer | Sale 10b5-1 | −130,352 | $39.41 | $5.1M | 94,203 |
| 2026-07-01 | Russell Alan J Chief Scientific Officer | Sale 10b5-1 | −69,648 | $39.41 | $2.7M | 24,555 |
| 2026-07-01 | Russell Alan J Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −130,352 | 0 | ||
| 2026-07-01 | Russell Alan J Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −69,648 | 1,077,717 | ||
| 2026-07-01 | Fox Jonathan C Director | Grant or award | +319 | 24,833 | ||
| 2026-06-05 | ROOT JONATHAN D Director | Grant or award · Stock Option (Right to Buy) | +16,377 | 16,377 | ||
| 2026-06-05 | Brege Laura Director | Grant or award · Stock Option (Right to Buy) | +16,377 | 16,377 | ||
| 2026-06-05 | Morris Arlene Director | Grant or award · Stock Option (Right to Buy) | +16,377 | 16,377 | ||
| 2026-06-05 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +16,377 | 16,377 | ||
| 2026-06-05 | Martin Christopher Nathan Director | Grant or award · Stock Options (Right to buy) | +16,377 | 16,377 | ||
| 2026-06-05 | Edris Badreddin Director | Grant or award · Restricted Stock Units | +5,619 | 5,619 | ||
| 2026-06-05 | Edris Badreddin Director | Grant or award · Stock Option (Right to Buy) | +8,188 | 8,188 | ||
| 2026-06-05 | Fox Jonathan C Director | Grant or award · Stock Option (Right to Buy) | +16,377 | 16,377 | ||
| 2026-05-05 | Donovan Joanne M. CMO | Option exercise | +50,000 | $7.08 | $354K | 54,367 |
| 2026-05-05 | Donovan Joanne M. CMO | Sale | −50,000 | $38.57 | $1.9M | 4,367 |
| 2026-05-05 | Donovan Joanne M. CMO | Option exercise · Stock Option (Right to Buy) | −50,000 | 75,000 | ||
| 2026-05-04 | Donovan Joanne M. CMO | Sale | −5,230 | $31.29 | $164K | 4,367 |
| 2026-04-01 | Fox Jonathan C Director | Grant or award | +339 | 24,514 |
Page 4 of 26 · 509 trades